Clinical Trials
-
{
- All
- News
- Videos
-
Ozempic Rival Retatrutide Delivers 25% Weight Loss In Phase 3 Trial
- Saturday October 3, 2026
- Science | Edited by Nikhil Pandey
An experimental weekly weight-loss injection called retatrutide helped people with obesity lose an average of up to 25 per cent of their body weight after 80 weeks in a Phase 3 trial.
-
www.ndtv.com
-
Are All Versions Of Semaglutide The Same? Doctor Answers
- Sunday October 4, 2026
- Health | Written by Dr Ritesh Agarwal
The original semaglutide was studied extensively in 50+ large-scale clinical trials and real-world settings, and has gathered 58 million patient years of exposure, providing insights into its long-term safety and efficacy, including effects on cardiovascular and metabolic health.
-
www.ndtv.com/health
-
No Evidence Of Liver Or Kidney Injury With Standardised Ashwagandha Root Extract In Clinical Trial
- Wednesday September 30, 2026
- Health | Press Trust Of India
The study also assessed whether prolonged administration of ashwagandha extract affected the immune response following the COVISHIELD vaccination.
-
www.ndtv.com/health
-
Ebola-Hit DR Congo Gets 70,000 Doses Of Ervebo Vaccine: WHO
- Thursday August 20, 2026
- Health | AFP
The World Health Organization said Thursday that the Ebola-hit Democratic Republic of Congo would receive 70,000 doses of a vaccine approved for protecting against the virus, but not...
-
www.ndtv.com/health
-
New HIV Pill Delivers Breakthrough Results In First Human Trial
- Saturday August 1, 2026
- Science | Edited by Nikhil Pandey
Researchers say the treatment appears safe and effective so far, although larger Phase 3 trials will be needed before it can be approved for widespread use.
-
www.ndtv.com
-
Copper Therapy Reduces Toxic Brain Proteins, Says Study: What Exactly Is It?
- Tuesday June 23, 2026
- Health | Written by Rupashi Chhabra
A new study highlights that copper therapy can reduce toxic brain proteins. Here is how this can happen and why the level of copper in your body influences brain health.
-
www.ndtv.com/health
-
Highly Effective Prevention Drug Arrives In South Africa, Which Has World's Highest HIV Burden
- Tuesday June 9, 2026
- Health | Associated Press
South Africa launches lenacapavir, a twice-yearly injectable HIV prevention drug, aiming to reduce new infections in the country with the highest HIV burden globally.
-
www.ndtv.com/health
-
WHO Urges Ebola Treatments, Vaccines Be Tested Only In Trials Amid Bundibugyo Outbreak
- Friday May 29, 2026
- Health | Written by Reuters
The World Health Organization said that experimental treatments and vaccines for Ebola caused by the Bundibugyo virus should only be used in clinical trials, as it works with affected countries to assess their safety and effectiveness.
-
www.ndtv.com/health
-
Bad Cholesterol Reduction: Single Gene Therapy Dose Shows 62% Drop
- Thursday May 28, 2026
- Health | Press Trust India
A one-time gene therapy for treating hypercholesterolaemia could lower up to 62 per cent 'bad' cholesterol in the blood, with reductions sustaining over time, according to results of a clinical trial published in The New England Journal of Medicine.
-
www.ndtv.com/health
-
ICMR Hosts First Annual Clinical Trial Meet To Boost Integrative Medicine Research
- Thursday May 21, 2026
- Health | Indo Asian Service News
The Indian Council of Medical Research (ICMR)'s multicentric Phase III clinical trial has found that Ayurvedic formulations are therapeutically equivalent to standard iron-folic acid supplementation in treating moderate iron deficiency anaemia among
-
www.ndtv.com/health
-
ICMR Hosts First Annual Clinical Trial Meet To Boost Integrative Medicine Research
- Thursday May 21, 2026
- Health | Indo Asian News Service
The Indian Council of Medical Research (ICMR)'s multicentric Phase III clinical trial has found that Ayurvedic formulations are therapeutically equivalent to standard iron-folic acid supplementation in treating moderate iron deficiency anaemia among
-
www.ndtv.com/health
-
Rare Epilepsy Breakthrough: Why This New Treatment Is Reducing Seizure Frequency In Children By 91%
- Friday March 6, 2026
- Health | Written by Rupashi Chhabra
An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by 91% in children. Here is what this breakthrough means for the children suffering from Dravet Syndrome.
-
www.ndtv.com/health
-
Rare Epilepsy Breakthrough: Why This New Treatment Is Reducing Seizure Frequency In Children By 91%
- Friday March 6, 2026
- Health | Written by Rupashi Chhabra
An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by 91% in children. Here is what this breakthrough means for the children suffering from Dravet Syndrome.
-
www.ndtv.com/health
-
Medical Trials To Now Focus On Indian Body Type, Data: New ICMR Mandate
- Wednesday February 11, 2026
- Health | Written by Rupashi Chhabra
The Indian Council of Medical Research has implemented a new mandate that prioritises clinical trials based on Indian body types and lifestyles for greater accuracy. Here is what you should know and why it matters.
-
www.ndtv.com/health
-
Medical Trials To Now Focus On Indian Body Type, Data: New ICMR Mandate
- Wednesday February 11, 2026
- Health | Written by Rupashi Chhabra
The Indian Council of Medical Research has implemented a new mandate that prioritises clinical trials based on Indian body types and lifestyles for greater accuracy. Here is what you should know and why it matters.
-
www.ndtv.com/health
-
Ozempic Rival Retatrutide Delivers 25% Weight Loss In Phase 3 Trial
- Saturday October 3, 2026
- Science | Edited by Nikhil Pandey
An experimental weekly weight-loss injection called retatrutide helped people with obesity lose an average of up to 25 per cent of their body weight after 80 weeks in a Phase 3 trial.
-
www.ndtv.com
-
Are All Versions Of Semaglutide The Same? Doctor Answers
- Sunday October 4, 2026
- Health | Written by Dr Ritesh Agarwal
The original semaglutide was studied extensively in 50+ large-scale clinical trials and real-world settings, and has gathered 58 million patient years of exposure, providing insights into its long-term safety and efficacy, including effects on cardiovascular and metabolic health.
-
www.ndtv.com/health
-
No Evidence Of Liver Or Kidney Injury With Standardised Ashwagandha Root Extract In Clinical Trial
- Wednesday September 30, 2026
- Health | Press Trust Of India
The study also assessed whether prolonged administration of ashwagandha extract affected the immune response following the COVISHIELD vaccination.
-
www.ndtv.com/health
-
Ebola-Hit DR Congo Gets 70,000 Doses Of Ervebo Vaccine: WHO
- Thursday August 20, 2026
- Health | AFP
The World Health Organization said Thursday that the Ebola-hit Democratic Republic of Congo would receive 70,000 doses of a vaccine approved for protecting against the virus, but not...
-
www.ndtv.com/health
-
New HIV Pill Delivers Breakthrough Results In First Human Trial
- Saturday August 1, 2026
- Science | Edited by Nikhil Pandey
Researchers say the treatment appears safe and effective so far, although larger Phase 3 trials will be needed before it can be approved for widespread use.
-
www.ndtv.com
-
Copper Therapy Reduces Toxic Brain Proteins, Says Study: What Exactly Is It?
- Tuesday June 23, 2026
- Health | Written by Rupashi Chhabra
A new study highlights that copper therapy can reduce toxic brain proteins. Here is how this can happen and why the level of copper in your body influences brain health.
-
www.ndtv.com/health
-
Highly Effective Prevention Drug Arrives In South Africa, Which Has World's Highest HIV Burden
- Tuesday June 9, 2026
- Health | Associated Press
South Africa launches lenacapavir, a twice-yearly injectable HIV prevention drug, aiming to reduce new infections in the country with the highest HIV burden globally.
-
www.ndtv.com/health
-
WHO Urges Ebola Treatments, Vaccines Be Tested Only In Trials Amid Bundibugyo Outbreak
- Friday May 29, 2026
- Health | Written by Reuters
The World Health Organization said that experimental treatments and vaccines for Ebola caused by the Bundibugyo virus should only be used in clinical trials, as it works with affected countries to assess their safety and effectiveness.
-
www.ndtv.com/health
-
Bad Cholesterol Reduction: Single Gene Therapy Dose Shows 62% Drop
- Thursday May 28, 2026
- Health | Press Trust India
A one-time gene therapy for treating hypercholesterolaemia could lower up to 62 per cent 'bad' cholesterol in the blood, with reductions sustaining over time, according to results of a clinical trial published in The New England Journal of Medicine.
-
www.ndtv.com/health
-
ICMR Hosts First Annual Clinical Trial Meet To Boost Integrative Medicine Research
- Thursday May 21, 2026
- Health | Indo Asian Service News
The Indian Council of Medical Research (ICMR)'s multicentric Phase III clinical trial has found that Ayurvedic formulations are therapeutically equivalent to standard iron-folic acid supplementation in treating moderate iron deficiency anaemia among
-
www.ndtv.com/health
-
ICMR Hosts First Annual Clinical Trial Meet To Boost Integrative Medicine Research
- Thursday May 21, 2026
- Health | Indo Asian News Service
The Indian Council of Medical Research (ICMR)'s multicentric Phase III clinical trial has found that Ayurvedic formulations are therapeutically equivalent to standard iron-folic acid supplementation in treating moderate iron deficiency anaemia among
-
www.ndtv.com/health
-
Rare Epilepsy Breakthrough: Why This New Treatment Is Reducing Seizure Frequency In Children By 91%
- Friday March 6, 2026
- Health | Written by Rupashi Chhabra
An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by 91% in children. Here is what this breakthrough means for the children suffering from Dravet Syndrome.
-
www.ndtv.com/health
-
Rare Epilepsy Breakthrough: Why This New Treatment Is Reducing Seizure Frequency In Children By 91%
- Friday March 6, 2026
- Health | Written by Rupashi Chhabra
An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by 91% in children. Here is what this breakthrough means for the children suffering from Dravet Syndrome.
-
www.ndtv.com/health
-
Medical Trials To Now Focus On Indian Body Type, Data: New ICMR Mandate
- Wednesday February 11, 2026
- Health | Written by Rupashi Chhabra
The Indian Council of Medical Research has implemented a new mandate that prioritises clinical trials based on Indian body types and lifestyles for greater accuracy. Here is what you should know and why it matters.
-
www.ndtv.com/health
-
Medical Trials To Now Focus On Indian Body Type, Data: New ICMR Mandate
- Wednesday February 11, 2026
- Health | Written by Rupashi Chhabra
The Indian Council of Medical Research has implemented a new mandate that prioritises clinical trials based on Indian body types and lifestyles for greater accuracy. Here is what you should know and why it matters.
-
www.ndtv.com/health